John Armitage - Egerton Capital (UK) LLP
Period: Q1 2026
Portfolio date: 31 Mar 2026
No. of stocks: 24
Portfolio value: $9,010,197,462
Holding/activity history for Vertex Pharmaceuticals (VRTX)
| Period |
Shares |
% of Portfolio |
Activity |
% Change to Portfolio |
Reported Price |
Value |
Filing |
| 2024 Q4 |
0 |
0.00 |
Sell 100.00%
|
0.58 |
|
|
SEC |
| 2024 Q3 |
124,045 |
0.58 |
Buy
|
0.58 |
$465.08 |
$57,690,849 |
SEC |